Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for CME Group Inc. (CME : NSDQ)
 
 • Company Description   
As the world's leading and most diverse derivatives marketplace, CME Group is where the world comes to manage risk. CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. Around the world, CME Group brings buyers and sellers together through its CME Globex electronic trading platform. CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. CME Group's products and services ensure that businesses around the world can effectively manage risk and achieve growth.

Number of Employees: 3,480

 
 • Price / Volume Information   
Yesterday's Closing Price: $192.11 Daily Weekly Monthly
20 Day Moving Average: 1,711,054 shares
Shares Outstanding: 359.42 (millions)
Market Capitalization: $69,048.37 (millions)
Beta: 0.47
52 Week High: $256.94
52 Week Low: $185.79
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -15.88% -5.26%
12 Week -19.03% -10.99%
Year To Date -15.91% 1.70%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
20 SOUTH WACKER DRIVE
-
CHICAGO,IL 60606
USA
ph: 312-930-1000
fax: 312-466-4410
info@cmegroup.com http://www.cmegroup.com
 
 • General Corporate Information   
Officers
Terrence A. Duffy - Chief Executive Officer;Chairman of the Board; Dir
John W. Pietrowicz - Senior Managing Director and Chief Financial Offic
Timothy S. Bitsberger - Director
Charles P. Carey - Director
Dennis H. Chookaszian - Director

Peer Information
CME Group Inc. (SOUM)
CME Group Inc. (CME)
CME Group Inc. (MKTX)
CME Group Inc. (NDAQ)
CME Group Inc. (CBOE)
CME Group Inc. (COIN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Securities Exchanges
Sector: Finance
CUSIP: 12572Q105
SIC: 6200
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 07/27/22
Share - Related Items
Shares Outstanding: 359.42
Most Recent Split Date: 7.00 (5.00:1)
Beta: 0.47
Market Capitalization: $69,048.37 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.08%
Current Fiscal Quarter EPS Consensus Estimate: $1.89 Indicated Annual Dividend: $4.00
Current Fiscal Year EPS Consensus Estimate: $7.90 Payout Ratio: 0.57
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.07
Estmated Long-Term EPS Growth Rate: 6.14% Last Dividend Paid: 03/09/2022 - $1.00
Next EPS Report Date: 07/27/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 24.33
Trailing 12 Months: 27.41
PEG Ratio: 3.96
Price Ratios
Price/Book: 2.49
Price/Cash Flow: 24.63
Price / Sales: 14.44
EPS Growth
vs. Year Ago Period: 17.88%
vs. Previous Quarter: 27.11%
Sales Growth
vs. Year Ago Period: 7.44%
vs. Previous Quarter: 17.37%
ROE
03/31/22 - 9.29
12/31/21 - 8.93
09/30/21 - 8.60
ROA
03/31/22 - 1.32
12/31/21 - 1.33
09/30/21 - 1.41
Current Ratio
03/31/22 - 1.02
12/31/21 - 1.01
09/30/21 - 1.01
Quick Ratio
03/31/22 - 1.02
12/31/21 - 1.01
09/30/21 - 1.01
Operating Margin
03/31/22 - 53.04
12/31/21 - 51.42
09/30/21 - 49.59
Net Margin
03/31/22 - 57.98
12/31/21 - 56.22
09/30/21 - 52.47
Pre-Tax Margin
03/31/22 - 73.96
12/31/21 - 71.94
09/30/21 - 67.00
Book Value
03/31/22 - 77.17
12/31/21 - 76.41
09/30/21 - 75.91
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.12
12/31/21 - 0.10
09/30/21 - 0.10
Debt-to-Capital
03/31/22 - 11.03
12/31/21 - 8.96
09/30/21 - 8.99
 

Powered by Zacks Investment Research ©